Understanding Collagen Cross-Linking (CXL)
Collagen Cross-Linking (CXL) is a minimally invasive procedure designed to treat keratoconus and other corneal weakening conditions. The procedure uses riboflavin (vitamin B2) eye drops and controlled UV light to strengthen corneal collagen fibers, stopping or slowing the progression of corneal thinning. CXL helps stabilize vision, prevent further deterioration, and may reduce the need for corneal transplantation in the future. It is safe, quick, and offers lasting benefits when done at an early stage of keratoconus.
Comprehensive Collagen Cross-Linking
Standard Epithelium-Off CXL
Epithelium-On (Transepithelial) CXL
Customized CXL Protocols
Long-Term Vision Preservation
Take the First Step Towards Clearer Vision
Stop Keratoconus Progression – Protect Your Vision Today!
Your Questions Answered
Faq
Who needs collagen cross-linking?
Patients diagnosed with keratoconus or other progressive corneal thinning disorders benefit the most, especially if caught early.
Is the procedure painful?
Mild discomfort or irritation can occur after the procedure, but numbing drops are used during treatment to keep you comfortable.
How long does it take?
The procedure typically lasts about 30–45 minutes per eye, and it is done on an outpatient basis.
Will my vision improve immediately?
Vision may be blurry for a few days to weeks after the procedure. The main goal is to halt disease progression, and vision often stabilizes or improves gradually over months.
Are there risks or side effects?
Temporary light sensitivity, mild pain, or haze can occur but usually resolve with proper care. Serious complications are rare.
Can keratoconus return after CXL?
CXL provides long-term stabilization, but regular follow-ups are necessary to monitor the cornea and ensure continued success.